ArticleBlood2018
Patients treated with oxaliplatin are at risk for thrombocytopenia caused by multiple drug-dependent antibodies.
Article in Blood, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Oxaliplatin-induced type II hypersensitivity in colorectal cancer: a cohort study on clinical presentation, diagnosis, and management.Frontiers in pharmacology · 2025Article
- Oxaliplatin-Induced Immune Thrombocytopenia in a Patient with Pancreatic Cancer.European journal of case reports in internal medicine · 2024Article
- Drug (vaccine)-induced thrombocytopenia 2021: Diversity of pathogenesis and clinical features.American journal of hematology · 2022Article
- Oxaliplatin hypersensitivity complicated by thrombocytopenia during desensitization.Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology · 2021Article
- Oxaliplatin-induced Immune Thrombocytopenia: A Case Report and Literature Review.Clinical colorectal cancer · 2021Review
- Thrombocytopenia Caused by Dexamethasone in a Patient with Colorectal Cancer.Internal medicine (Tokyo, Japan) · 2020Article
- Acute Immune-Mediated Thrombocytopenia due to Oxaliplatin and Irinotecan Therapy.Case reports in oncological medicine · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.